Transdermal therapeutic system (tts) containing tolterodine

Details Transdermal therapeutic system (tts) containing tolterodine Transdermal therapeutic system (tts) containing tolterodine

A - Human Necessities

61

K

A61K 9/70 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01) A61K 9/14 (2006.01)

Patent

CA 2373629

The invention relates to a transdermal therapeutic system (TTS) for transcutaneously administering tolterodine over a period of several days and to a method for producing the same. The TTS contains a self-adhesive layer- shaped matrix material which contains a (meth)acrylate copolymer comprising ammonium groups. The TTS also contains at least one softener and up to 25 wt. % of tolterodine.

L'invention concerne un système thérapeutique transdermique (STT) pour administrer par voie transcutanée de la Toltérodine sur plusieurs jours, ainsi qu'un procédé permettant de le préparer. Ce STT comprend une matière matricielle auto-adhésive stratiforme qui contient un polymère (méth)acrylate contenant des groupes ammonium, au moins un plastifiant et jusqu'à 25 % en poids de Toltérodine.

Affiliated with

Also associated with

Rating

Transdermal therapeutic system (tts) containing tolterodine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal therapeutic system (tts) containing tolterodine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal therapeutic system (tts) containing tolterodine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1411047